Heart failure Trials in Riga, Latvia
Conditions / Heart failure / Riga, Latvia
Clinical trials for Heart failure investigate a range of treatment strategies and patient populations.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03037931 | Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study | COMPLETED | PHASE3 |
| NCT02111564 | A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients | COMPLETED | PHASE3 |
| NCT01877915 | A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure | COMPLETED | PHASE3 |
| NCT05636176 | A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation | RECRUITING | PHASE3 |
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | TERMINATED | PHASE3 |
| NCT00358215 | RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial | COMPLETED | PHASE3 |
| NCT03521934 | Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) | TERMINATED | PHASE3 |
| NCT06215911 | A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF) | COMPLETED | PHASE2 |
| NCT04435626 | Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% | COMPLETED | PHASE3 |
| NCT02831608 | Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis | COMPLETED | PHASE4 |